Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: Single-center retrospective study of 9 patients

Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: Single-center retrospective study of 9 patients

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of the American Academy of Dermatology - Volume 66, Issue 2, February 2012, Pages 328-332

Thomas MD, Caroline MD, MSc, Michel MD, Florence MD, Céleste MD, PhD, Patrice MD, Abdellatif MD, PhD, Fabien MD, MSc,